Kasper Madsen

5PUBLICATIONS
54CO-AUTHORS
Epidemiological modellingGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 07, 2026
Cardiotoxicity, survival, and dexrazoxane use in patients with soft tissue sarcoma: a Danish population‑based cohort study.

|May 18, 2026
Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.

|May 12, 2025
Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.

Inna M Chen, Julia S Johansen, Susann Theile

|Jun 14, 2024
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.

Alice Markussen, Julia S Johansen, Finn O Larsen

|Feb 15, 2024
Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.

Høgni H Andersen, Stig E Bojesen, Julia S Johansen

Pageof 1

Frequent Collaborators

3 joint publications

Dorte Nielsen

2 joint publications

Julia S Johansen

2 joint publications

Inna M Chen

2 joint publications

Inge Marie Svane